Coronavirus Update - 14th October 2020

Despite the recent rises in Covid-19 cases throughout the UK and Europe, Arcinova remains open for business at full capacity as we have done throughout this pandemic. As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Webinars from the Arcinova team

October 13, 2020

ADME/Human AME Virtual Symposium - Recent insights on optimizing your ADME/hAME study

About this Event In this recorded webinar you can join experts from
August 5, 2020

The Need for Speed: gaining the right support to accelerate your small molecule candidate

About this Event This digital event was hosted by Arcinova and featu
July 6, 2020

Preformulation to FIH: avoiding pitfalls for early clinical success

About this Event Preformulation characterization of new chemical ent
June 1, 2020

Latest hybrid LC-MS techniques to resolve your peptide analytical questions.

Michael Blackburn, Bioanalytical Scientist (Method Development), Bioanalytical Servicest, here at Arcinova, discusses using MSIA with mass spectrometry to analyse therapeutic pe
March 12, 2020

API Development Using Flow Chemistry & Synthetic Biology

Find our more about API Development using Flow Chemistry & Synthetic Biology with Paul Quigley, Head of Drug Substance and Isotope Labelling. 
June 12, 2019

New Perspectives in Flow Chemistry

Pharmaceutical companies are currently investing in the development of continuous chemical processes to reduce costs and accelerate the delivery of new molecules to the market. While the spotlight